BioStrand BV, part of ImmunoPrecise Antibodies Ltd., is a company headquartered in Diepenbeek, Belgium, that provides biotechnology and bioinformatics solutions. It was founded in 2019 by Ingrid Brands and Dirk Van Hyfte. Ingrid Brands has been the CEO since the inception date. ImmunoPrecise Netherlands BV acquired BioStrand BV on April 14, 2022 for $35.10 million.\nThe company says this about itself: BioStrand BV is a private limited liability company, incorporated under the laws of Belgium. The business of BioStrand BV focuses on technology, in the field of bioinformatics and biotechnology, for handling of biological sequences including for example processing, storing and comparing biological sequence information, and for generating biological sequence information, software development, algorithms, data visualisation and visual analytics, which can for example be applied in the field of molecular diagnostics, point of care testing, in depth analysis for drug development, prediction, construction and adaptation of biopolymer sequences as well as a product, service, or tool which stores this information in a database.